Author:
Choi Peter J.,Lu Guo-Liang,Sutherland Hamish S.,Giddens Anna C.,Franzblau Scott G.,Cooper Christopher B.,Denny William A.,Palmer Brian D.
Funder
Irish Aid
Department for International Development, UK Government
United States Agency for International Development
Bill and Melinda Gates Foundation
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Reference30 articles.
1. World Health Organization, Antimicrobial resistance, 2020.
2. World Health Organization, Global tuberculosis report 2020, 2020.
3. Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial;Tweed;Lancet Respiratory Med.,2019
4. Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline;Blaser;Biorg. Med. Chem.,2019
5. Synthetic Studies to Help Elucidate the Metabolism of the Preclinical Candidate TBAJ-876-A Less Toxic and More Potent Analogue of Bedaquiline;Choi;Molecules,2020
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献